V1 sact_regimen
730,471 rows · 12 columns
| MERGED_REGIMEN_ID | MERGED_TUMOUR_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | MERGED_PATIENT_ID | BENCHMARK_GROUP |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 220006010 | 220002341 | 1.7 | 61.4 | Curative (C) | 2017-04-26 | 2017-04-26 | AML 19 TRIAL | Y | N | 220029438 | AML19 TRIAL |
| 220006011 | 220002341 | 1.66 | 87.2 | Curative (C) | 2016-04-02 | 2016-04-06 | AML 19 TRIAL | Y | N | 220029438 | AML19 TRIAL |
| 220006012 | 220002342 | 0 | null | Curative (C) | 2017-01-31 | 2017-01-31 | Nilotinib | null | null | 220029444 | NILOTINIB |
| 220006013 | 220002343 | 0 | null | Curative (C) | 2013-10-10 | 2013-10-12 | BMT Fludarabine/Thiotepa/Treosulfan + ATG | 2 | N | 220029445 | NOT MATCHED |
| 220006014 | 220002343 | 1.68 | 72.3 | Curative (C) | 2016-12-31 | 2017-01-01 | AML 19 TRIAL | N | N | 220029445 | AML19 TRIAL |
| 220006015 | 220002343 | 1.77 | 88.6 | Curative (C) | 2017-12-13 | 2017-12-21 | FLAG + Idarubicin | N | N | 220029445 | FLAG + IDARUBICIN |
| 220006016 | 220002343 | 1.8 | 69.1 | Curative (C) | 2017-02-01 | 2017-02-02 | AML 19 TRIAL | N | N | 220029445 | AML19 TRIAL |
| 220006017 | 220002343 | 0 | 0 | Curative (C) | 2016-12-22 | 2016-12-22 | Nilotinib | N | N | 220029445 | NILOTINIB |
| 220006018 | 220002343 | 1.64 | 75 | Curative (C) | 2013-07-12 | 2013-07-25 | FLAG + Idarubicin | 2 | Y | 220029445 | FLAG + IDARUBICIN |
| 220006019 | 220002343 | 0 | null | Curative (C) | 2017-05-25 | 2017-05-25 | Nilotinib | 2 | N | 220029445 | NILOTINIB |
| 220006020 | 220002344 | null | 13.6 | Curative (C) | 2017-03-28 | 2017-03-29 | FBC Conditionining | 2 | N | 220029461 | NOT MATCHED |
| 220006021 | 220002344 | 1.64 | 67.8 | Not known (9) | 2014-07-30 | 2014-07-30 | Nilotinib | N | N | 220029461 | NILOTINIB |
| 220006022 | 220002345 | null | 0 | Curative (C) | 2017-07-24 | 2017-07-24 | Nilotinib | 02 | N | 220029464 | NILOTINIB |
| 220006023 | 220002345 | 1.88 | 81.5 | Curative (C) | 2015-09-06 | 2015-09-06 | AML 19 TRIAL | N | null | 220029464 | AML19 TRIAL |
| 220006024 | 220002346 | 1.65 | null | Curative (C) | 2014-05-05 | 2014-05-05 | AML 19 TRIAL | 01 | N | 220029467 | AML19 TRIAL |
| 220006025 | 220002346 | 1.78 | 80.3 | Curative (C) | 2015-10-10 | 2015-10-10 | AML 19 TRIAL | Y | N | 220029467 | AML19 TRIAL |
| 220006026 | 220002346 | 1.67 | null | Adjuvant (A) | 2013-01-11 | 2013-01-18 | null | Y | N | 220029467 | NOT MATCHED |
| 220006027 | 220002347 | 1.92 | null | Palliative (P) | 2013-01-10 | 2013-01-10 | FLAG + Idarubicin | N | N | 220029479 | FLAG + IDARUBICIN |
| 220006030 | 220002348 | 1.8 | 55.2 | Curative (C) | 2015-12-02 | 2015-12-03 | AML 19 TRIAL | 1 | N | 220029484 | AML19 TRIAL |
| 220006031 | 220002348 | 0 | null | Curative (C) | 2017-05-09 | 2017-05-10 | Nilotinib | 02 | N | 220029484 | NILOTINIB |
| 220006032 | 220002349 | 1.64 | null | Not known (9) | 2016-10-03 | 2016-10-03 | Nilotinib | 02 | N | 220029486 | NILOTINIB |
| 220006033 | 220002349 | null | null | Curative (C) | 2015-05-23 | 2015-05-27 | Nilotinib | N | N | 220029486 | NILOTINIB |
| 220006034 | 220002349 | 1.61 | null | Curative (C) | null | 2016-01-10 | Nilotinib | 2 | N | 220029486 | NILOTINIB |
| 220006036 | 220011319 | null | 7 | Palliative (P) | 2015-05-04 | 2015-05-04 | null | N | N | 220029493 | NOT MATCHED |
| 220006037 | 220016075 | null | null | Disease modification (D) | 2016-09-15 | 2016-09-25 | Nilotinib | N | N | 220029496 | NILOTINIB |
| 220006038 | 220016075 | 1.85 | 0 | Curative (C) | 2014-11-18 | 2014-11-18 | Nilotinib | 02 | N | 220029496 | NILOTINIB |
| 220006039 | 220016075 | null | 56.9 | Curative (C) | 2013-06-17 | 2013-06-17 | FLAG + Idarubicin | null | N | 220029496 | FLAG + IDARUBICIN |
| 220006040 | 220016075 | 1.72 | 76.1 | Curative (C) | 2015-01-30 | 2015-01-30 | FLAG + Idarubicin | N | N | 220029496 | FLAG + IDARUBICIN |
| 220006041 | 220016075 | 1.59 | 77 | Curative (C) | 2016-04-27 | 2016-04-28 | AML 19 TRIAL | Y | N | 220029496 | AML19 TRIAL |
| 220006042 | 220016075 | null | null | Curative (C) | 2015-11-22 | 2015-11-22 | AML MyeChild | N | N | 220029496 | NOT MATCHED |
| 220006043 | 220016075 | 1.61 | 76.9 | Curative (C) | 2017-01-10 | 2017-01-12 | AML 19 TRIAL | Y | N | 220029496 | AML19 TRIAL |
| 220006044 | 220002351 | null | null | Not known (9) | 2018-04-17 | 2018-04-20 | Nilotinib | N | N | 220029508 | NILOTINIB |
| 220006045 | 220002351 | 1.59 | 95 | Curative (C) | 2015-01-18 | 2015-01-21 | AML 19 TRIAL | 1 | N | 220029508 | AML19 TRIAL |
| 220006046 | 220002352 | 1.75 | 86.5 | Curative (C) | 2013-11-05 | 2013-11-11 | FLAG + Idarubicin | N | N | 220029510 | FLAG + IDARUBICIN |
| 220006047 | 220002353 | 0 | 0 | Disease modification (D) | null | 2013-09-26 | Nilotinib | 2 | N | 220029514 | NILOTINIB |
| 220006048 | 220002354 | 1.76 | null | Curative (C) | 2014-08-19 | 2014-08-19 | FLAG + Idarubicin | N | N | 220029518 | FLAG + IDARUBICIN |
| 220006049 | 220002355 | null | 0 | Palliative (P) | 2016-06-11 | 2016-06-11 | Nilotinib | N | N | 220029519 | NILOTINIB |
| 220006050 | 220011321 | null | null | Curative (C) | 2017-07-07 | 2017-07-07 | null | N | N | 220029520 | NOT MATCHED |
| 220006051 | 220002356 | null | 0 | Disease modification (D) | null | 2014-06-09 | Nilotinib | N | N | 220029521 | NILOTINIB |
| 220006052 | 220002357 | 1.72 | 61.9 | Curative (C) | 2017-02-16 | 2017-02-16 | AML 19 TRIAL | N | N | 220029522 | AML19 TRIAL |
| 220006053 | 220002358 | null | 0 | Not known (9) | 2014-01-27 | 2014-01-27 | Nilotinib | N | N | 220029523 | NILOTINIB |
| 220006054 | 220002358 | 1.5 | 62.2 | Curative (C) | 2015-08-31 | 2015-08-31 | AML 19 TRIAL | Y | N | 220029523 | AML19 TRIAL |
| 220006055 | 220002358 | 1.75 | 98.6 | Curative (C) | 2013-09-18 | 2013-09-19 | AML 19 TRIAL | 01 | N | 220029523 | AML19 TRIAL |
| 220006056 | 220002359 | null | 91 | Palliative (P) | 2014-03-09 | 2014-03-09 | Nilotinib | 2 | N | 220029529 | NILOTINIB |
| 220006057 | 220002359 | 1.83 | null | Disease modification (D) | 2015-10-27 | 2015-10-27 | Nilotinib | N | N | 220029529 | NILOTINIB |
| 220006061 | 220018795 | 0 | null | Disease modification (D) | null | 2013-06-03 | Nilotinib | N | N | 220029539 | NILOTINIB |
| 220006062 | 220018795 | 0 | null | Curative (C) | null | 2015-02-12 | null | 2 | N | 220029539 | NOT MATCHED |
| 220006063 | 220018795 | 1.65 | null | Curative (C) | 2014-07-18 | 2014-07-18 | Nilotinib | N | N | 220029539 | NILOTINIB |
| 220006064 | 220002361 | 0 | null | null | 2016-04-11 | 2016-04-11 | Nilotinib | N | N | 220029546 | NILOTINIB |
| 220006066 | 220002363 | 0 | 90 | Curative (C) | 2015-04-06 | 2015-04-13 | Nilotinib | 02 | N | 220029559 | NILOTINIB |